Day One Biopharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 53.7M | 39.8M | 33.9M | 30.8M | 29.2M | 93.8M | 8.2M | 0 |
| Cost of Goods Sold | 6.1M | 4.5M | 3.8M | 2.9M | 3.0M | 1.6M | 707K | 0 |
| Gross Profit | 47.6M | 35.3M | 30.1M | 27.9M | 26.2M | 92.2M | 7.5M | 0 |
| R&D Expenses | 40.9M | 31.4M | 36.1M | 39.6M | 61.8M | 33.6M | 92.1M | 40.2M |
| Operating Expenses | 75.1M | 59.6M | 65.1M | 68.9M | 91.6M | 62.5M | 122.3M | 66.8M |
| Operating Income | -27.5M | -24.3M | -35.0M | -41.1M | -65.3M | 29.6M | -114.8M | -66.8M |
| Other Income / Gains | 4.2M | 4.5M | 4.7M | 5.1M | 6.1M | 6.5M | 112.0M | 4.4M |
| Net Income | -21.3M | -19.7M | -30.3M | -36.0M | -65.7M | 37.0M | -4.4M | -62.4M |
| EPS (Diluted) | -0.21 | -0.19 | -0.29 | -0.35 | -0.70 | 0.38 | -0.051 | -0.72 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.887 | 0.887 | 0.889 | 0.906 | 0.898 | 0.983 | 0.914 | 0 |
| General And Administrative Expenses | 0 | 0 | 0 | 29.3M | 0 | 0 | 0 | 26.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 34.1M | 28.1M | 29.0M | 29.3M | 29.7M | 29.0M | 30.2M | 26.6M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 81.2M | 64.0M | 68.9M | 71.8M | 94.5M | 64.1M | 123.0M | 66.8M |
| Interest Income | 4.1M | 4.6M | 4.7M | 5.1M | 6.1M | 5.3M | 4.0M | 4.4M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 994K | 934K | 964K | 894K | 759K | 746K | 408K | 116K |
| Ebitda | -26.5M | -23.3M | -34.0M | -40.2M | -64.6M | 30.4M | -114.4M | -66.7M |
| Ebitdaratio | -0.493 | -0.586 | -1.003 | -1.306 | -2.211 | 0.324 | -13.965 | 0 |
| Operating Income Ratio | -0.511 | -0.609 | -1.031 | -1.335 | -2.237 | 0.316 | -14.015 | 0 |
| Income Before Tax | -23.3M | -19.7M | -30.3M | -36.0M | -59.2M | 36.2M | -2.9M | -62.4M |
| Income Before Tax Ratio | -0.433 | -0.496 | -0.894 | -1.17 | -2.028 | 0.386 | -0.349 | 0 |
| Income Tax Expense | -2.0M | 0 | 0 | 0 | 6.5M | -882K | 1.6M | 0 |
| Net Income Ratio | -0.396 | -0.496 | -0.894 | -1.17 | -2.25 | 0.395 | -0.538 | 0 |
| Epsdiluted | -0.21 | -0.19 | -0.29 | -0.35 | -0.70 | 0.38 | -0.051 | -0.72 |
| Weighted Average Shs Out | 103.4M | 103.4M | 103.1M | 102.7M | 93.6M | 96.6M | 87.1M | 86.7M |
| Weighted Average Shs Out Dil | 103.4M | 103.4M | 103.1M | 102.7M | 93.6M | 96.9M | 87.1M | 86.7M |